Pulmonary Function at Presentation and Follow-up in Hemato-Oncology 3-7 Years Old Children

NCT00552825 | Completed

• 2 other identifiers: SHEBA-05-3889-OE-CTILObservational
• Study Type: observational
• Target: 35
• Locations: 1 country
• Sites: 1

Brief Summary

The aim of this study was to investigate the occurrences of respiratory symptoms risk factors and abnormalities in lung function in young children (3-6 years old) with hemato-oncologic diseases at presentation (before treatment) and up to 3 years follow-up (study period).

Conditions

Acute Lymphoblastic Leukemia; Acute Myeloblastic Leukemia; Solid Tumors,; Hodgkin's Disease; Non-Malignant

Keywords

acute lymphoblastic leukemia; long-term lung function

Study Arms (1)

1

all were in a single group

Eligibility Criteria

• Age: 3 Years - 7 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Child (0-17)
• Sampling Method: Non-Probability Sample

Study Population

All pediatric patients (age 3-7 years) with hemato-onclogic diseases that were treated at the Hemato-Oncology Department, and were sent to the pediatric pulmonary unit at the Safra children's hospital, Sheba medical center, Ramat-Gan, Israel, to perform lung function tests, as a part of a 3-year follow-up study.

You may qualify if:

• All pediatric patients (age 3-7 years) with hemato-onclogic diseases that were treated at the Hemato-Oncology Department, and were sent to the pediatric pulmonary unit.

Sponsors & Collaborators

• Sheba Medical Center: lead

Study Sites (1)

Sheba Medical CenterPediatric pulmonary unit, Pulmonary function laboratory

Ramat Gan, Ramat Gan, 52621, Israel

Location

MeSH Terms

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma; Leukemia, Myeloid, Acute; Hodgkin Disease

Condition Hierarchy (Ancestors)

Leukemia, Lymphoid; Leukemia; Neoplasms by Histologic Type; Neoplasms; Hematologic Diseases; Hemic and Lymphatic Diseases; Lymphoproliferative Disorders; Lymphatic Diseases; Immunoproliferative Disorders; Immune System Diseases; Leukemia, Myeloid; Lymphoma

Study Officials

• Ori Efrati, MD

  Sheba Medical Center

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: RETROSPECTIVE
• Sponsor Type: OTHER GOV

Study Record Dates

• First Submitted: November 1, 2007
• First Posted: November 2, 2007
• Study Start: October 1, 2005
• Study Completion: October 1, 2006
• Last Updated: November 2, 2007

Record last verified: 2007-11

Locations

IL (1)